Comparing two plasma p-tau217 assays for Alzheimer’s detection and monitoring

Researchers compared two commercially available blood tests based on the biomarker p-tau217 for diagnosing Alzheimer’s disease in 294 patients. Both tests demonstrated robust diagnostic capabilities, strongly correlating with established Alzheimer’s biomarkers from PET scans.

The US Biosecure Act threatens to destabilise the pharmaceutical industry – Pharmaceutical Technology

In January this year, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act,

July 17, 2024

Global stock market crash likely to delay biotech IPOs – Pharmaceutical Technology

Biotech IPOs raised a total of $3.72bn in the first quarter of this year. Image credit: Shutterstock / ImageFlow. Initial public offerings (IPOs) for biotechs

August 6, 2024

U.S. appeals court strikes down key provisions in Oklahoma law that regulates PBMs

A U.S. appeals court struck down key parts of an Oklahoma law designed to regulate the retail networks created by pharmacy benefit managers, dealing a

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.